Viatris Inc. (NASDAQ: VTRS) is facing heightened investor scrutiny after Levi & Korsinsky LLP, a nationally recognized securities litigation firm, announced an investigation into potential violations of federal securities laws. This move comes in the wake of Viatris’s disappointing financial results and regulatory challenges that sent its stock price tumbling by over 15% on February 27, 2025.
Viatris’s Fourth Quarter and Full-Year 2024 Earnings Miss Estimates
On February 27, 2025, Viatris released its Q4 and full-year 2024 financial results, which fell short of consensus estimates across key metrics. The company also provided lower-than-expected guidance for 2025, raising concerns among investors about its future profitability and growth prospects.
Regulatory Troubles: FDA Import Alert and Facility Remediation in India
Adding to the company’s challenges, Viatris provided an update on its remediation efforts at a manufacturing facility in India, which had been flagged by the U.S. Food and Drug Administration (FDA) with a warning letter and an import alert. According to the company, remediation efforts are more than halfway complete, and Viatris anticipates requesting an FDA reinspection in the coming months.
Stock Plummets as Investors React
Following the news, Viatris’s stock price plunged more than 15% in a single trading day, reflecting investor concerns over the company’s operational and regulatory setbacks.
Levi & Korsinsky Investigates Potential Securities Violations
Levi & Korsinsky LLP has launched an investigation into Viatris Inc. to determine whether the company violated federal securities laws, potentially misleading investors regarding its financial health and regulatory compliance. The firm encourages shareholders who suffered losses to explore their legal options.
About Levi & Korsinsky LLP
Levi & Korsinsky LLP has built a formidable reputation over the past two decades as a leading securities litigation firm, securing hundreds of millions of dollars in recoveries for shareholders. With a team of over 70 employees, the firm specializes in complex securities cases and has consistently ranked among the top securities litigation firms in the U.S. for seven consecutive years, according to ISS Securities Class Action Services’ Top 50 Report.
Investors with concerns about their Viatris holdings can contact Joseph E. Levi, Esq., for further details on potential legal claims.
